Alignment: Moderna was central to the COVID-19 vaccine push that became politically polarizing. The company has standard pharma DEI programs but does not lead on social-issue advocacy. Mixed.
Summary
Moderna was central to the COVID-19 vaccine push that became politically polarizing. The company has standard pharma DEI programs but does not lead on social-issue advocacy. Mixed.
Claims & Sources
Claim 1: Trump administration paid Moderna $1.5 billion for vaccine candidate
Sources: Public Citizen — Trump-Moderna deal
Claim 2: Moderna declined to share COVID-19 vaccine rights with the government that funded development
Sources: The Conversation — Moderna vaccine rights
Claim 3: Vaccine makers including Moderna funneled undisclosed campaign cash in 2020
Sources: The Intercept — Vaccine makers dark money